MSP Recovery EBITDA Margin 2020-2024 | MSPR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for MSP Recovery (MSPR) over the last 10 years. The current EBITDA margin for MSP Recovery as of September 30, 2024 is .
| MSP Recovery EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.01B | $-0.05B | -481.82% |
| 2024-06-30 | $0.01B | $-0.06B | -857.14% |
| 2024-03-31 | $0.01B | $-0.07B | -650.00% |
| 2023-12-31 | $0.01B | $-0.08B | -1037.50% |
| 2023-09-30 | $0.01B | $-0.08B | -1050.00% |
| 2023-06-30 | $0.02B | $-0.08B | -476.47% |
| 2023-03-31 | $0.02B | $-0.09B | -473.68% |
| 2022-12-31 | $0.02B | $-0.06B | -278.26% |
| 2022-09-30 | $0.03B | $-0.04B | -141.94% |
| 2022-06-30 | $0.02B | $-0.03B | -141.67% |
| 2022-03-31 | $0.02B | $-0.01B | -36.36% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.014B | $0.008B |
| MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.190B | 54.80 |
| Tempus AI (TEM) | United States | $7.943B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.493B | 165.11 |
| Inspire Medical Systems (INSP) | United States | $5.665B | 176.68 |
| IRhythm Technologies (IRTC) | United States | $3.468B | 0.00 |
| Privia Health (PRVA) | United States | $2.722B | 226.80 |
| Enovis (ENOV) | United States | $2.627B | 17.81 |
| Azenta (AZTA) | United States | $2.466B | 131.66 |
| Clover Health Investments (CLOV) | United States | $2.160B | 0.00 |
| 10x Genomics (TXG) | United States | $1.974B | 0.00 |
| Omnicell (OMCL) | United States | $1.974B | 64.58 |
| Schrodinger (SDGR) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.582B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.837B | 0.00 |
| Standard BioTools (LAB) | United States | $0.681B | 0.00 |
| Talkspace (TALK) | United States | $0.534B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.519B | 0.00 |
| TruBridge (TBRG) | United States | $0.342B | 99.65 |
| Health Catalyst (HCAT) | United States | $0.341B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| Pulmonx (LUNG) | United States | $0.239B | 0.00 |
| American Well (AMWL) | United States | $0.158B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| CareCloud (CCLD) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |